|
|
||||||||||
|
J Am Coll Cardiol, 1997; 29:549-555 © 1997 by the American College of Cardiology Foundation |
University of Stellenbosch, Tygerberg, Republic of South Africa.
OBJECTIVES: This study was designed to verify initial observations of the clinical and prognostic features of hypertrophic cardiomyopathy caused by cardiac tropnin T gene mutations. BACKGROUND: The most common cause of sudden cardiac death in the young is hypertrophic cardiomyopathy, which is usually familial. Mutations causing familial hypertrophic cardiomyopathy have been identified in a number of contractile protein genes, raising the possibility of genetic screening for subjects at risk. A previous report suggested that mutations in the cardiac troponin T gene were notable because they were associated with a particularly poor prognosis but only mild hypertrophy. Given the variability of some genotype:phenotype correlations, further analysis of cardiac troponin T mutations has been a priority. METHODS: Deoxyribonucleic acid from subjects with hypertrophic cardiomyopathy was screened for cardiac troponin T mutations using a ribonuclease protection assay. Polymerase chain reaction-based detection of a novel mutation was used to genotype members of two affected pedigrees. Gene carriers were examined by echocardiography and electrocardiology, and a family history was obtained. RESULTS: A novel cardiac troponin T gene mutation, arginine 92 tryptophan, was identified in 19 of 48 members of two affected pedigrees. The clinical phenotype was characterized by minimal hypertrophy (mean [+/-SD] maximal ventricular wall thickness 11.3 +/- 5.4 mm) and low disease penetrance by clinical criteria (40% by echocardiography) but a high incidence of sudden cardiac death (mean age 17 +/- 9 years). CONCLUSIONS: These data support the observation that apparently diverse cardiac troponin T gene mutations produce a consistent disease phenotype. Because this is one of poor prognosis, despite deceptively mild or undetectable hypertrophy, genotyping at this locus may be particularly informative in patient management and counselling.
This article has been cited by other articles:
![]() |
O. M. Hernandez, M. Jones, G. Guzman, and D. Szczesna-Cordary Myosin essential light chain in health and disease Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1643 - H1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frey, K. Brixius, R. H. G. Schwinger, T. Benis, A. Karpowski, H. P. Lorenzen, M. Luedde, H. A. Katus, and W. M. Franz Alterations of Tension-dependent ATP Utilization in a Transgenic Rat Model of Hypertrophic Cardiomyopathy J. Biol. Chem., October 6, 2006; 281(40): 29575 - 29582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Debl, B Djavidani, S Buchner, C Lipke, W Nitz, S Feuerbach, G Riegger, and A Luchner Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis Heart, October 1, 2006; 92(10): 1447 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Ho and C. E. Seidman A Contemporary Approach to Hypertrophic Cardiomyopathy Circulation, June 20, 2006; 113(24): e858 - e862. [Full Text] [PDF] |
||||
![]() |
E. Ladich, R. Virmani, and A. Burke Sudden Cardiac Death not Related to Coronary Atherosclerosis Toxicol Pathol, January 1, 2006; 34(1): 52 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Ertz-Berger, H. He, C. Dowell, S. M. Factor, T. E. Haim, S. Nunez, S. D. Schwartz, J. S. Ingwall, and J. C. Tardiff Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice PNAS, December 13, 2005; 102(50): 18219 - 18224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Perkins, S. L. Van Driest, E. G. Ellsworth, M. L. Will, B. J. Gersh, S. R. Ommen, and M. J. Ackerman Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy Eur. Heart J., November 2, 2005; 26(22): 2457 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chandra, M. L. Tschirgi, and J. C. Tardiff Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2112 - H2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rickers, N. M. Wilke, M. Jerosch-Herold, S. A. Casey, P. Panse, N. Panse, J. Weil, A. G. Zenovich, and B. J. Maron Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy Circulation, August 9, 2005; 112(6): 855 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Adabag, S. A. Casey, M. A. Kuskowski, A. G. Zenovich, and B. J. Maron Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 1, 2005; 45(5): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J.G. Seidman, and C. E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2125 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada and J. D. Potter Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction J. Biol. Chem., April 9, 2004; 279(15): 14488 - 14495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Arking, S. S. Chugh, A. Chakravarti, and P. M. Spooner Genomics in Sudden Cardiac Death Circ. Res., April 2, 2004; 94(6): 712 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF] |
||||
![]() |
M. Garcia-Castro, J. R. Reguero, A. Batalla, B. Diaz-Molina, P. Gonzalez, V. Alvarez, A. Cortina, G. I. Cubero, and E. Coto Hypertrophic Cardiomyopathy: Low Frequency of Mutations in the {beta}-Myosin Heavy Chain (MYH7) and Cardiac Troponin T (TNNT2) Genes among Spanish Patients Clin. Chem., August 1, 2003; 49(8): 1279 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Van Driest, E. G. Ellsworth, S. R. Ommen, A. J. Tajik, B. J. Gersh, and M. J. Ackerman Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy * Note Added in Proof Circulation, July 29, 2003; 108(4): 445 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crilley, E. A. Boehm, E. Blair, B. Rajagopalan, A. M. Blamire, P. Styles, W. J. McKenna, I. Ostman-Smith, K. Clarke, and H. Watkins Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1776 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, C. Pichereau, A. Benaiche, R. Isnard, O. Dubourg, M. Burban, et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy Circulation, May 6, 2003; 107(17): 2227 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Knollmann, P. Kirchhof, S. G. Sirenko, H. Degen, A. E. Greene, T. Schober, J. C. Mackow, L. Fabritz, J. D. Potter, and M. Morad Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling Circ. Res., March 7, 2003; 92(4): 428 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arad, J.G. Seidman, and C. E. Seidman Phenotypic diversity in hypertrophic cardiomyopathy Hum. Mol. Genet., October 1, 2002; 11(20): 2499 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ackerman, S. L. VanDriest, S. R. Ommen, M. L. Will, R. A. Nishimura, A. J. Tajik, and B. J. Gersh Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy: A comprehensive outpatient perspective J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Andersen, O. Havndrup, H. Bundgaard, J. C. Moolman-Smook, L. A. Larsen, J. Mogensen, P. A. Brink, A. D. Borglum, V. A. Corfield, K. Kjeldsen, et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations J. Med. Genet., December 1, 2001; 38 (12): e43 - e43. [Full Text] [PDF] |
||||
![]() |
D. Li, G. Z. Czernuszewicz, O. Gonzalez, T. Tapscott, A. Karibe, J.-B. Durand, R. Brugada, R. Hill, J. M. Gregoritch, J. L. Anderson, et al. Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy Circulation, October 30, 2001; 104(18): 2188 - 2193. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Janse and J.M.T. De Bakker Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L15 - L20. [Abstract] [PDF] |
||||
![]() |
H. Watkins Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L43 - L50. [Abstract] [PDF] |
||||
![]() |
A. M. Varnava, P. M. Elliott, C. Baboonian, F. Davison, M. J. Davies, and W. J. McKenna Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease Circulation, September 18, 2001; 104(12): 1380 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, H. Niimura, S. A. Casey, M. K. Soper, G. B. Wright, J. G. Seidman, and C. E. Seidman Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations J. Am. Coll. Cardiol., August 1, 2001; 38(2): 315 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Priori, C. Napolitano, and M. Grillo Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res, May 1, 2001; 50(2): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Hernandez, P. R. Housmans, and J. D. Potter Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation J Appl Physiol, March 1, 2001; 90(3): 1125 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin, R. M. Graham, P. Spirito, and B. J. Maron Prognostic Value of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy N. Engl. J. Med., January 4, 2001; 344(1): 63 - 65. [Full Text] [PDF] |
||||
![]() |
J. MOOLMAN-SMOOK, W. DE LANGE, V. CORFIELD, and P. BRINK Expression of HCM causing mutations: lessons learnt from genotype-phenotype studies of the South African founder MYH7 A797T mutation J. Med. Genet., December 1, 2000; 37(12): 951 - 956. [Full Text] |
||||
![]() |
C. Y. Ho, H. M. Lever, R. DeSanctis, C. F. Farver, J. G. Seidman, and C. E. Seidman Homozygous Mutation in Cardiac Troponin T : Implications for Hypertrophic Cardiomyopathy Circulation, October 17, 2000; 102(16): 1950 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G D'CRUZ, C. BABOONIAN, H. E PHILLIMORE, R. TAYLOR, P. M ELLIOTT, A. VARNAVA, F. DAVISON, W. J MCKENNA, and N. D CARTER Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy J. Med. Genet., September 1, 2000; 37(9): 18e - 18. [Full Text] |
||||
![]() |
H. Kokado, M. Shimizu, H. Yoshio, H. Ino, K. Okeie, Y. Emoto, T. Matsuyama, M. Yamaguchi, T. Yasuda, N. Fujino, et al. Clinical Features of Hypertrophic Cardiomyopathy Caused by a Lys183 Deletion Mutation in the Cardiac Troponin I Gene Circulation, August 8, 2000; 102(6): 663 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frey, W. M. Franz, K. Gloeckner, M. Degenhardt, M. Muller, O. Muller, H. Merz, and H. A. Katus Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias Cardiovasc Res, August 1, 2000; 47(2): 254 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.C. Saumarez and A.A. Grace Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases Cardiovasc Res, July 1, 2000; 47(1): 11 - 22. [Full Text] [PDF] |
||||
![]() |
C Wren, J J O'Sullivan, and C Wright Sudden death in children and adolescents Heart, April 1, 2000; 83(4): 410 - 413. [Abstract] [Full Text] |
||||
![]() |
J. A. Moolman, S. Reith, K. Uhl, S. Bailey, M. Gautel, B. Jeschke, C. Fischer, J. Ochs, W. J. McKenna, H. Klues, et al. A Newly Created Splice Donor Site in Exon 25 of the MyBP-C Gene Is Responsible for Inherited Hypertrophic Cardiomyopathy With Incomplete Disease Penetrance Circulation, March 28, 2000; 101(12): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Doevendans Hypertrophic Cardiomyopathy : Do We Have the Algorithm for Life and Death? Circulation, March 21, 2000; 101(11): 1224 - 1226. [Full Text] [PDF] |
||||
![]() |
D. Szczesna, R. Zhang, J. Zhao, M. Jones, G. Guzman, and J. D. Potter Altered Regulation of Cardiac Muscle Contraction by Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy J. Biol. Chem., January 7, 2000; 275(1): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Varnava, C Baboonian, F Davison, L de Cruz, P M Elliott, M J Davies, and W J McKenna A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy Heart, November 1, 1999; 82(5): 621 - 624. [Abstract] [Full Text] |
||||
![]() |
C. S. Redwood, J. C. Moolman-Smook, and H. Watkins Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy Cardiovasc Res, October 1, 1999; 44(1): 20 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yanaga, S. Morimoto, and I. Ohtsuki Ca2+ Sensitization and Potentiation of the Maximum Level of Myofibrillar ATPase Activity Caused by Mutations of Troponin T Found in Familial Hypertrophic Cardiomyopathy J. Biol. Chem., March 26, 1999; 274(13): 8806 - 8812. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hinkle, A. Goranson, C. A. Butters, and L. S. Tobacman Roles for the Troponin Tail Domain in Thin Filament Assembly and Regulation. A DELETIONAL STUDY OF CARDIAC TROPONIN T J. Biol. Chem., March 12, 1999; 274(11): 7157 - 7164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, J. Barhanin, R. N. W. Hauer, W. Haverkamp, H. J. Jongsma, A. G. Kleber, W. J. McKenna, D. M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II Circulation, February 2, 1999; 99(4): 518 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.G. Priori, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management Eur. Heart J., February 1, 1999; 20(3): 174 - 195. [PDF] |
||||
![]() |
H. L. Sweeney, H. S. Feng, Z. Yang, and H. Watkins Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function PNAS, November 24, 1998; 95(24): 14406 - 14410. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF] |
||||
![]() |
G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects Circ. Res., September 21, 1998; 83(6): 580 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Anan, H. Shono, A. Kisanuki, S. Arima, S. Nakao, and H. Tanaka Patients With Familial Hypertrophic Cardiomyopathy Caused by a Phe110Ile Missense Mutation in the Cardiac Troponin T Gene Have Variable Cardiac Morphologies and a Favorable Prognosis Circulation, August 4, 1998; 98(5): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Charron, O. Dubourg, M. Desnos, M. Bennaceur, L. Carrier, A.-C. Camproux, R. Isnard, A. Hagege, J. M. Langlard, G. Bonne, et al. Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene Circulation, June 9, 1998; 97(22): 2230 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Knollmann, S. A. Blatt, K. Horton, F. de Freitas, T. Miller, M. Bell, P. R. Housmans, N. J. Weissman, M. Morad, and J. D. Potter Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy J. Biol. Chem., March 23, 2001; 276(13): 10039 - 10048. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |